/Companies

Aperontrials

Cambridge, US · Founded 2026 · 1 known investors

Find your way into Aperontrials

Sign up to see every warm intro you have to Aperontrials

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Aperontrials team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Aperon builds a documentation layer for clinical trials, creating a continuous, auditable record of trial operations grounded in the study protocol. It serves trial sponsors seeking oversight of clinical trial execution.

Founders & leadership

JL
Joshua Louis MoscatoNamed on SEC filing

Investors · 1

Reported raises · per SEC filings

Form D private placements

$505K disclosed across 1 round · 2026

▶$505KraisedAug 2026 · 7 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Joshua Louis MoscatoExecutive Officer, Director
Amount sold
$505K
Proceeds to insiders
$70K
First sale
Jul 2026
Incorporated
Corporation, Delaware, 2026
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Aperontrials do?
Aperon builds a documentation layer for clinical trials, creating a continuous, auditable record of trial operations grounded in the study protocol. It serves trial sponsors seeking oversight of clinical trial execution.
Who are Aperontrials's investors?
Aperontrials's investors include Stone Mountain Ventures.
How much funding has Aperontrials raised?
Aperontrials has disclosed $505K raised across 1 round.
Where is Aperontrials headquartered?
Aperontrials is headquartered in Cambridge, US.